Do Day Dream Public Company Limited Stocks

THB 5.25Last Updated 27.04.2026

Issuer Rating

3/7
Performance

Average

Risk

Considerable

Recommendation

Sell

Market Cap

THB 50.80M

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
THB 5.25
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Do Day Dream Public Company Limited, together with its subsidiaries, manufactures and distributes skin care products and supplements in Thailand. The company operates through Skincare business and Beauty Products business segments. It offers acne-prone and sensitive skin products under OXE'CURE; skin care and deep-nourishing products under SOS; hair styling appliance under LESASHA; oral care products, including toothpastes and toothbrushes under SPARKLE; and fitness equipment under JASON brands. In addition, the company provides home electrical appliance under AT HOME; hair removal devices under EMJOI; intense pulse light hair removal devices under SMOOTH SKIN; beauty innovation products under Kuron; and electrical appliance for cooking under BEAR brands. Do Day Dream Public Company Limited was incorporated in 2010 and is headquartered in Bangkok, Thailand.

Company Valuation

Overvalued
2/7

Based on key historical and expected multiples, the stock is overvalued relative to its peers. In particular, the stock is overpriced on P/E, overvalued on P/FC.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks